Progestogens are used during pregnancy for threatened miscarriage, recurrent miscarriage, and prevention of preterm labor. Vaginal administration of progesterone results in targeted uterine delivery with minimal systemic effects. It increases endometrial tissue levels more than oral or injectable routes. Progestogen treatment reduces miscarriage risk by 47% for threatened miscarriage and 29% for recurrent miscarriage. For preterm labor prevention in singletons, vaginal progesterone reduces risk with a short cervix while injectable 17-OH PC works for prior preterm labor. In twins, vaginal progesterone only helps if the cervix is short.